Sign in

CIK 0001819411

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Gain Therapeutics, Inc.

Sign in to watch
Ticker
GANX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
851726310
Phone
+1 301-500-1556
Business address
4800 HAMPDEN LANE, SUITE 200, BETHESDA, MD, 20814
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-07-15 Islam Khalid Director Grant or award · Stock Option (right to buy) +25,000 25,000
2025-06-24 Islam Khalid Director Grant or award · Stock Option (right to buy) +15,000 15,000
2024-08-09 Islam Khalid Executive Chairman Purchase +50,000 $1.00 $50K 50,000
2024-06-24 Islam Khalid Director Grant or award · Stock Option (right to buy) +15,000 15,000
2023-06-23 Islam Khalid Director Grant or award · Stock Option (right to buy) +10,500 10,500
2022-09-20 Islam Khalid Director Grant or award · Stock Option (right to buy) +10,500 10,500

Page 1 of 1 · 6 trades